Histamine, leukotriene D4 and platelet-activating factor in guinea pig passive cutaneous anaphylaxis
- PMID: 1687219
- DOI: 10.1016/0014-2999(91)90700-z
Histamine, leukotriene D4 and platelet-activating factor in guinea pig passive cutaneous anaphylaxis
Abstract
The involvement of histamine, leukotriene D4 (LTD4) and platelet-activating factor (PAF) in cutaneous anaphylaxis was investigated in a guinea pig model. When given alone, the H1 receptor antagonist chlorpheniramine, the LTD4/E4 antagonist LY171883 and the PAF antagonist WEB2086 were unable to inhibit increased microvascular plasma protein leakage in passive cutaneous anaphylaxis (PCA) reactions, as monitored by the extravasation of intravenously injected 125I-albumin. Furthermore the H2 receptor antagonist cimetidine and the serotonin antagonist methysergide were unable to reduce PCA responses when given alone or in combination with chlorpheniramine. In marked contrast, combinations of antagonists were able to reduce plasma leakage significantly. A combination of chlorpheniramine, LY171883 and WEB2086 virtually abolished plasma leakage during the PCA response, but did not influence the plasma protein leakage induced by intradermal injection of bradykinin. These results demonstrate that these allergic reactions involve several mediators and that the inability of an individual mediator antagonist to reduce responses does not necessarily rule out a role for that mediator.
Similar articles
-
Investigation of the endogenous chemoattractants involved in 111In-eosinophil accumulation in passive cutaneous anaphylactic reactions in the guinea-pig.Br J Pharmacol. 1994 Sep;113(1):35-42. doi: 10.1111/j.1476-5381.1994.tb16170.x. Br J Pharmacol. 1994. PMID: 7812629 Free PMC article.
-
Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats.Agents Actions. 1988 Jun;24(1-2):189-95. doi: 10.1007/BF01968100. Agents Actions. 1988. PMID: 3407549
-
Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin.Br J Pharmacol. 1991 Sep;104(1):128-32. doi: 10.1111/j.1476-5381.1991.tb12396.x. Br J Pharmacol. 1991. PMID: 1664758 Free PMC article.
-
Platelet activating factor--a mediator of inflammation in the skin--medical implications.Clin Exp Dermatol. 1993 Nov;18(6):489-95. doi: 10.1111/j.1365-2230.1993.tb01015.x. Clin Exp Dermatol. 1993. PMID: 8252783 Review. No abstract available.
-
Chemical mediators in hypersensitivity reactions.Acta Paediatr Jpn. 1990 Apr;32(2):209-15. doi: 10.1111/j.1442-200x.1990.tb00813.x. Acta Paediatr Jpn. 1990. PMID: 1974103 Review.
Cited by
-
Inflammatory mechanisms in the passive cutaneous anaphylactic reaction in the rabbit: evidence that novel mediators are involved.Br J Pharmacol. 1992 Dec;107(4):1163-72. doi: 10.1111/j.1476-5381.1992.tb13424.x. Br J Pharmacol. 1992. PMID: 1281720 Free PMC article.
-
Investigation of the endogenous chemoattractants involved in 111In-eosinophil accumulation in passive cutaneous anaphylactic reactions in the guinea-pig.Br J Pharmacol. 1994 Sep;113(1):35-42. doi: 10.1111/j.1476-5381.1994.tb16170.x. Br J Pharmacol. 1994. PMID: 7812629 Free PMC article.
-
Effects of phosphodiesterase isoenzyme inhibitors on cutaneous inflammation in the guinea-pig.Br J Pharmacol. 1994 May;112(1):332-40. doi: 10.1111/j.1476-5381.1994.tb13073.x. Br J Pharmacol. 1994. PMID: 8032659 Free PMC article.
-
A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo.Br J Pharmacol. 1999 Apr;126(8):1863-71. doi: 10.1038/sj.bjp.0702520. Br J Pharmacol. 1999. PMID: 10372831 Free PMC article.
-
A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo.J Exp Med. 1993 Feb 1;177(2):561-6. doi: 10.1084/jem.177.2.561. J Exp Med. 1993. PMID: 8381157 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources